Search

Karl E. Group

Examiner (ID: 16968, Phone: (571)272-1368 , Office: P/1731 )

Most Active Art Unit
1731
Art Unit(s)
1108, 1731, 1755, 2899, 1793
Total Applications
4063
Issued Applications
3169
Pending Applications
125
Abandoned Applications
770

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17577036 [patent_doc_number] => 20220133891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => HEMOSTATIC MICROSPHERES [patent_app_type] => utility [patent_app_number] => 17/574229 [patent_app_country] => US [patent_app_date] => 2022-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574229 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/574229
HEMOSTATIC MICROSPHERES Jan 11, 2022 Abandoned
Array ( [id] => 17539920 [patent_doc_number] => 11305024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-19 [patent_title] => Cross-linked polymer modified nanoparticles [patent_app_type] => utility [patent_app_number] => 17/398954 [patent_app_country] => US [patent_app_date] => 2021-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 119 [patent_no_of_words] => 29281 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398954 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/398954
Cross-linked polymer modified nanoparticles Aug 9, 2021 Issued
Array ( [id] => 18517667 [patent_doc_number] => 11707538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides [patent_app_type] => utility [patent_app_number] => 17/150186 [patent_app_country] => US [patent_app_date] => 2021-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 4790 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150186 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/150186
Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides Jan 14, 2021 Issued
Array ( [id] => 16596478 [patent_doc_number] => 20210023009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 17/071418 [patent_app_country] => US [patent_app_date] => 2020-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17071418 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/071418
NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY Oct 14, 2020 Abandoned
Array ( [id] => 16824096 [patent_doc_number] => 20210139389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [ AT 211] RADIOPHARMACEUTICALS [patent_app_type] => utility [patent_app_number] => 17/060810 [patent_app_country] => US [patent_app_date] => 2020-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8647 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060810 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/060810
Automatic process platform for the production of astatine-211 [At-211]-radiopharmaceuticals Sep 30, 2020 Issued
Array ( [id] => 16991943 [patent_doc_number] => 20210230363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => DERIVATIVES OF 1,3-PROPANEDIOL [patent_app_type] => utility [patent_app_number] => 17/014055 [patent_app_country] => US [patent_app_date] => 2020-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7041 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014055 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/014055
DERIVATIVES OF 1,3-PROPANEDIOL Sep 7, 2020 Abandoned
Array ( [id] => 17458825 [patent_doc_number] => 20220072129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => NOBLE METAL NANOPARTICLES WITH RADIAL PORES AND METHODS FOR ANTITUMOR TREATMENTS [patent_app_type] => utility [patent_app_number] => 17/012820 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6567 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012820 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/012820
Noble metal nanoparticles with radial pores Sep 3, 2020 Issued
Array ( [id] => 16236716 [patent_doc_number] => 20200253950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => Pharmaceutical Formulations Comprising CCR3 Antagonists [patent_app_type] => utility [patent_app_number] => 16/861473 [patent_app_country] => US [patent_app_date] => 2020-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8262 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861473 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/861473
Pharmaceutical formulations comprising CCR3 antagonists Apr 28, 2020 Issued
Array ( [id] => 18780181 [patent_doc_number] => 11821892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Nanobubbles [patent_app_type] => utility [patent_app_number] => 16/851130 [patent_app_country] => US [patent_app_date] => 2020-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 53 [patent_no_of_words] => 18324 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851130 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/851130
Nanobubbles Apr 16, 2020 Issued
Array ( [id] => 16221342 [patent_doc_number] => 20200246458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-06 [patent_title] => METHOD FOR TREATING CANCER BASED ON METALLOFULLERENE MONOCRYSTALLINE NANOPARTICLES THAT SPECIFICALLY DISRUPT TUMOR BLOOD VESSELS [patent_app_type] => utility [patent_app_number] => 16/837953 [patent_app_country] => US [patent_app_date] => 2020-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4573 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16837953 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/837953
METHOD FOR TREATING CANCER BASED ON METALLOFULLERENE MONOCRYSTALLINE NANOPARTICLES THAT SPECIFICALLY DISRUPT TUMOR BLOOD VESSELS Mar 31, 2020 Abandoned
Array ( [id] => 15738541 [patent_doc_number] => 20200108158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-09 [patent_title] => TARGETED CONTRAST AGENTS AND METHODS FOR TARGETING CONTRAST AGENTS [patent_app_type] => utility [patent_app_number] => 16/689718 [patent_app_country] => US [patent_app_date] => 2019-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689718 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/689718
TARGETED CONTRAST AGENTS AND METHODS FOR TARGETING CONTRAST AGENTS Nov 19, 2019 Abandoned
Array ( [id] => 15342329 [patent_doc_number] => 20200009056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => ORGANIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/576217 [patent_app_country] => US [patent_app_date] => 2019-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16576217 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/576217
ORGANIC COMPOUNDS Sep 18, 2019 Abandoned
Array ( [id] => 16009105 [patent_doc_number] => 20200179395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/574367 [patent_app_country] => US [patent_app_date] => 2019-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16574367 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/574367
PHARMACEUTICAL COMPOSITIONS Sep 17, 2019 Abandoned
Array ( [id] => 15797339 [patent_doc_number] => 20200121812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's Disease [patent_app_type] => utility [patent_app_number] => 16/555915 [patent_app_country] => US [patent_app_date] => 2019-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555915 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/555915
Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's Disease Aug 28, 2019 Abandoned
Array ( [id] => 15114231 [patent_doc_number] => 20190343748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-14 [patent_title] => VERSATILE TOPICAL DRUG DELIVERY VEHICLE AND MULTIFACTORIAL TISSUE MOISTURIZER THAT PROVIDES MUCOSAL AND SKIN BARRIER RESTORATION [patent_app_type] => utility [patent_app_number] => 16/518434 [patent_app_country] => US [patent_app_date] => 2019-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 317 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16518434 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/518434
VERSATILE TOPICAL DRUG DELIVERY VEHICLE AND MULTIFACTORIAL TISSUE MOISTURIZER THAT PROVIDES MUCOSAL AND SKIN BARRIER RESTORATION Jul 21, 2019 Abandoned
Array ( [id] => 17065913 [patent_doc_number] => 20210268128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => FLUORESCENT NANOPARTICLES AND IMAGING USES [patent_app_type] => utility [patent_app_number] => 17/253959 [patent_app_country] => US [patent_app_date] => 2019-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15141 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253959 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/253959
FLUORESCENT NANOPARTICLES AND IMAGING USES Jul 8, 2019 Abandoned
Array ( [id] => 15020979 [patent_doc_number] => 20190321494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-24 [patent_title] => POLYMALIC ACID BASED NANOCONJUGATES FOR IMAGING [patent_app_type] => utility [patent_app_number] => 16/434545 [patent_app_country] => US [patent_app_date] => 2019-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16373 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16434545 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/434545
POLYMALIC ACID BASED NANOCONJUGATES FOR IMAGING Jun 6, 2019 Abandoned
Array ( [id] => 14716035 [patent_doc_number] => 20190249081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => MORPHOLOGICALLY AND SIZE UNIFORM MONODISPERSE PARTICLES AND THEIR SHAPE-DIRECTED SELF-ASSEMBLY [patent_app_type] => utility [patent_app_number] => 16/396058 [patent_app_country] => US [patent_app_date] => 2019-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396058 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/396058
MORPHOLOGICALLY AND SIZE UNIFORM MONODISPERSE PARTICLES AND THEIR SHAPE-DIRECTED SELF-ASSEMBLY Apr 25, 2019 Abandoned
Array ( [id] => 14655747 [patent_doc_number] => 20190235002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors [patent_app_type] => utility [patent_app_number] => 16/381874 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4520 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381874 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/381874
Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors Apr 10, 2019 Abandoned
Array ( [id] => 18719272 [patent_doc_number] => 11796610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Compositions as molecular tags for hyperpolarization NMR and magnetic resonance and methods of making and using same [patent_app_type] => utility [patent_app_number] => 16/298621 [patent_app_country] => US [patent_app_date] => 2019-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 10459 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298621 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/298621
Compositions as molecular tags for hyperpolarization NMR and magnetic resonance and methods of making and using same Mar 10, 2019 Issued
Menu